Arteriosclerosis and arterial calcifications in chronic kidney insufficiency;Artériosclérose et calcifications vasculaires dans l'insuffisance rénale chronique

Nephrologie et Therapeutique

Volumn 1, Issue SUPPL. 4, 2005, Pages

  London, Gérard M ^a  

^a Centre Hospitalier FH Manhes   (France)

Author keywords

Atherosclerosis; Calcifications; End stage Renal Disease; Hyperphosphatemia

Indexed keywords

CALCIMIMETIC AGENT; CALCIUM; FETUIN; LANTHANUM; OSTEOGENIC PROTEIN 1; OSTEOPONTIN; PARATHYROID HORMONE[1-34]; PHOSPHATE; SEVELAMER; SODIUM PHOSPHATE COTRANSPORTER; VITAMIN D;

ARTERIOSCLEROSIS; ARTERY CALCIFICATION; BIOACCUMULATION; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CORONARY ARTERY BLOOD FLOW; CYTOLOGY; DISEASE ASSOCIATION; GENE EXPRESSION; HEART AFTERLOAD; HEART LEFT VENTRICLE; HUMAN; HYPERPHOSPHATEMIA; OSTEOBLAST; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; PRESCRIPTION; PREVENTIVE MEDICINE; REVIEW; RIGIDITY; SECONDARY HYPERPARATHYROIDISM;

ARTERIOSCLEROSIS; CALCINOSIS; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 29744464745     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112-9.
2. Lindner A, Charra B, Sherrard D, Scribner BM. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-702.
3. London GM, Drüeke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int 1997;51:1678-95.
4. Braun J, Oldendorf M, Moshage W, et al. Electron beam computed tomography in the evaluation of cardiac calcifications in chronic dialysis patients. Am J Kidney Dis 1996;27:394-401.
5. Goodman WG, Goldin J, Kuizon BD, et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-83.
6. Guérin AP, London GM, Marchais SJ, Métivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000;15:1014-21.
7. Blacher J, Guérin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938-42.
8. London GM, Guérin AP, Marchais SJ, et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003;18:1731-40.
9. Wang AY, Wang M, Woo J, et al. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 2003;14:159-68.
10. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 1994;93:2393-402.
11. Proudfoot D, Skepper JN, Shanahan CM, Weissberg PL. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low level of osteopontin expression. Atheroscler Thromb Vasc Biol 1998;18:379-88.
12. Shanahan CM, Cary NRB, Salisbury JR, et al. Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999; 100:2168-76.
13. Moe SM, O'Neill KD, Duan D, et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix protein. Kiddney Int 2002;61:638-47.
14. Steitz SA, Speer ME, Curinga G, et al. Smooth muscle cell phenotypic transition associated with calcification. Upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001;89:1147-54.
15. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000;87:E10-7.
16. Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004;15:2857-67.
17. Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int 2004;66:2293-9.
18. Wada T, McKee MD, Steitz S, Giachelli CM. Calcification of vascular smooth muscle cells: inhibition by osteopontin. Circ Res 1999;84:166-78.
19. Speer MY, McKee MD, Guldberg RE, et al. Inactivation of osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as a, inductible inhibitor of vascular calcification in vivo. J Exp Med 2002;196:1047-55.
20. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998;12:1260-8.
21. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386:78-81.
22. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 2001;60:472-9.
23. Price PA, Williamson MK, Haba T, et al. Excessive mineralization with growth plate closure in rats on chronic warfarin treatment. Proc Natl Acad Sci U S A 1982;79:7734-8.
24. Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-66.
25. Schinke T, Amendt C, Trindl A, et al. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 2001;271:20789-96.
26. Lomashvili K, Cobbs S, Hennigar RA, et al. Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol 2004;15:1392-401.
27. Moe SM, Duan D, Doehle BP, et al. Uremia induces the osteoblast differentiation factor Cbfal in human blood vessels. Kidney Int 2003;63:1003-11.
28. Jono S, Nishizawa Y, Shioi A, Morii H. 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid-hormone related peptide. Circulation 1998;98:1302-6.
29. Jono S, Nishizawa Y, Shioi A, Morii H. Parathyroid-related peptide as a local regulator of vascular calcification. Its inhibitory action on in vitro calcification by bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:1135-43.
30. Shao JS, Cheng SL, Charlton-Kachigian N, et al. Teriparatide [human parathyroid hormone- (1-34)] inhibits osteogenic vascular calcification in diabetes low density lipoprotein receptor-deficient mice. J Biol Chem 2003;278(50):50195-200.
31. London GM, Marty C, Marchais SJ, et al. Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 2004;15:1943-51.
32. Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003;361:827-33.
33. Tintut Y, Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via cAMP pathway. Circulation 2000;102:2636-42.
34. Parhami F, Basseri B, Hwang J, et al. High-density lipoprotein regulates calcification of vascular cells. Circ Res 2002;91:570-6.
35. Wang TJ, Larson MG, Levy D, et al. C-Reactive protein is associated with subclinical epicardial coronary calcification in men and women the Framingham Heart Study. Circulation 2002;106:1189-91.
36. Wang AYM, Woo J, Wang M, et al. Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 2001;12:1927-36.
37. D'Haese PC, Spasovski GB, Sikole A, et al. Multicenter study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int 2003;Suppl 85:573-8.
38. Chertow GM, Burke SK, Raggi P, et al. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patient. Kidney Int 2002;62:245-52.
39. Chertow GM, Raggi P, McCarthy JT, et al. The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients. Am J Nephrol 2003;23:307-14.
40. Davies MR, Lund RJ, Hruska KA. BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol 2003;14:1559-67.
41. Steitz SA, Speer MY, McKee MD, et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 2002;161:2035-46.